Biocept, Inc.
BIOC
BIOC was delisted on the 24th of October, 2023.
26 hedge funds and large institutions have $1.57M invested in Biocept, Inc. in 2022 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 7 reducing their positions, and 4 closing their positions.
2,650% more call options, than puts
Call options by funds: $110K | Put options by funds: $4K
4% less funds holding
Funds holding: 27 → 26 (-1)
12% less capital invested
Capital invested by funds: $1.78M → $1.57M (-$209K)
25% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 4
86% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 7
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$19.4K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$12.2K |
| 3 |
Carson Wealth (CWM LLC)
Omaha,
Nebraska
|
+$11K |
| 4 |
Simplex Trading
Chicago,
Illinois
|
+$414 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$65.2K |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$47.5K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
-$37.5K |
| 4 |
VF
Virtu Financial
New York
|
-$27K |
| 5 |
Group One Trading
Chicago,
Illinois
|
-$15.6K |
BIOC Hedge Fund Activity: Q3 2022 in Review
26 of the 5,806 institutional investors tracked by Wall St. Rank reported a position in Biocept, Inc. (BIOC) for Q3 2022, worth a combined $1.57M — down 12% from $1.78M a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of BIOC and 3 opened new positions — a net loss of 1 holder — while 7 trimmed existing stakes and 1 added.
The largest buyer was Susquehanna International Group, opening a new position worth an estimated $19.4K. The largest seller was Millennium Management, cutting an estimated $65.2K.
- 26 institutional investors held Biocept, Inc. (BIOC) as of Q3 2022, down from 27 in Q2 2022.
- Funds reported $1.57M of Biocept, Inc. stock for Q3 2022, down 12% quarter-over-quarter.
- 3 funds opened new Biocept, Inc. positions in Q3 2022 and 4 closed out, a net change of -1 holder.
- The largest Biocept, Inc. buyer in Q3 2022 was Susquehanna International Group, an estimated $19.4K added.
- The largest Biocept, Inc. seller in Q3 2022 was Millennium Management, an estimated $65.2K sold.
Based on aggregated 13F filings for Q3 2022.